SCHEMBL6779240

SCHEMBL6779240

O=C(c1sc2ccccc2c1Cl)N(Cc1cccnc1)Cc1ccccc1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ KMT2A Q03164 3/20 0.50
▸ GAA P10253 1/20 0.50
▸ CD274 Q9NZQ7 1/20 0.48
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ FNTA P49354 1/20 0.43
▸ FNTB P49356 1/20 0.43
▸ GPBAR1 Q8TDU6 4/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ HTR2C P28335 1/20 0.41
▸ MCL1 Q07820 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784951 0.84 KMT2A (0.44) HPGDLMNAKMT2AGAACD274
SCHEMBL3456574 0.79 CD274 (0.70) HPGDLMNAKMT2ACD274CYP3A4
SCHEMBL6779489 0.79 CLK1 (0.48) LMNAKMT2ANPSR1GPBAR1ALDH1A1
SCHEMBL6778426 0.75 KMT2A (0.48) HPGDKMT2AGAANPSR1FNTA
SCHEMBL6780567 0.74 GPBAR1 (0.49) LMNAKMT2AGAANPSR1FNTA
SCHEMBL6777732 0.73 LPAR1 (0.52) HPGDKMT2AGAANPSR1ALDH1A1
SCHEMBL6779730 0.73 GPBAR1 (0.44) KMT2AGAAFNTAFNTBGPBAR1
SCHEMBL6779237 0.72 RXFP1 (0.50) HPGDLMNAKMT2AGAACYP3A4
SCHEMBL6785255 0.72 LMNA (0.51) HPGDLMNAKMT2AGAACYP3A4
SCHEMBL6774110 0.72 SGMS2 (0.50) KMT2ACD274ALDH1A1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT HPGD 677/4885LMNA 4203/4885KMT2A 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback